Overview

A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
This is a multicenter study to evaluate the safety and efficacy of ezetimibe/simvastatin versus rosuvastatin in participants with high cholesterol.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Calcium
Ezetimibe
Ezetimibe, Simvastatin Drug Combination
Rosuvastatin Calcium
Simvastatin